OQS
XERS icon

Occudo Quantitative Strategies’s Xeris Biopharma Holdings XERS Stock Holding History

Occudo Quantitative Strategies’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,674
Closed -$388K – 931
2025
Q3 		$388K Sell
47,674
-131,680
-73% -$875K 0.05% 444
2025
Q2 		$838K Buy
179,354
+58,930
+49% +$270K 0.09% 263
2025
Q1 		$672K Buy
120,424
+68,687
+133% +$277K 0.09% 308
2024
Q4 		$175K Buy
51,737
+18,952
+58% +$61K 0.03% 590
2024
Q3 		$93.4K Buy
+32,785
New +$84.2K 0.02% 642
2023
Q3 		– Sell
-127,091
Closed -$333K – 1349
2023
Q2 		$333K Buy
+127,091
New +$324K 0.03% 708

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Occudo Quantitative Strategies's XERS Position: Q4 2025 in Review

Occudo Quantitative Strategies sold out of Xeris Biopharma Holdings (XERS) in Q4 2025, closing a stake of 47,674 shares — an estimated $388K sold.

Occudo Quantitative Strategies first reported a position in XERS in Q2 2023 and held it in 6 quarters. The position peaked at $838K in Q2 2025. 225 funds tracked by Wall St. Rank hold XERS as of Q4 2025.

  • Occudo Quantitative Strategies reported no remaining Xeris Biopharma Holdings position as of Q4 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 47,674 Xeris Biopharma Holdings shares in Q4 2025, an estimated $388K.
  • Occudo Quantitative Strategies first reported a position in Xeris Biopharma Holdings in Q2 2023 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Xeris Biopharma Holdings position peaked at $838K in Q2 2025.
  • 225 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.